A randomized, prospective, two-center comparison of sirolimus-eluting stent and zotarolimus-eluting stent in acute ST-elevation myocardial infarction: the SEZE trial.

@article{Chung2012ARP,
  title={A randomized, prospective, two-center comparison of sirolimus-eluting stent and zotarolimus-eluting stent in acute ST-elevation myocardial infarction: the SEZE trial.},
  author={Woo-Young Chung and Jeehoon Kang and Young Seok Cho and Hae-Jun Park and H O Yang and Jae-Bin Seo and Jung Won Suh and Kwang-il Kim and Tae Jin Youn and Sanghyun Kim and In Ho Chae and Joo-Hee Zo and Myung-A Kim and Dong Ju Choi},
  journal={Chinese medical journal},
  year={2012},
  volume={125 19},
  pages={3373-81}
}
BACKGROUND The zotarolimus-eluting stent has shown larger in-stent late lumen loss compared to sirolimus-eluting stents in previous studies. However, this has not been thoroughly evaluated in ST elevation myocardial infarction. METHODS This was a prospective, randomized, controlled trial evaluating angiographic outcomes in patients presenting with ST elevation myocardial infarction, treated with zotarolimus-eluting stents or sirolimus-eluting stents. From March 2007 to February 2009, 122… CONTINUE READING